The aim of the present study is to evaluate the prognostic value of MMP-14 and MMP-2 expression in ovarian cancer, as determined by semi-quantitative immunohistochemistry, in a large regional cohort. The gene discussed is MMP14; the disease is ovarian carcinoma.